A Phase I, Open-Label, Dose-Finding and Food Effect Study of Oral Clofarabine in Previously Treated Adult Patients With Myelodysplastic Syndromes (MDS).
Phase of Trial: Phase I
Latest Information Update: 27 May 2015
At a glance
- Drugs Clofarabine (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions
- Sponsors Sanofi; Sanofi Genzyme
- 08 Apr 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 26 Sep 2008 New trial record.